EMD Millipore, the Life Science division of Merck KGaA, has entered an exclusive agreement to sell recombinant human insulin manufactured by Julphar Diabetes, a pharmaceutical production company based in the United Arab Emirates. The insulin is of non-animal origin and will be marketed under EMD Millipore’s CellPrime brand. CellPrime Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines, according ...